SYNAGEVA BIOPHARMA CORP Insider Trading for April 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNAGEVA BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SYNAGEVA BIOPHARMA CORP for April 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Option Exercise | M | 1.70 | 10,000 | 17,000 | 37,228 | |
| Apr 29 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Sell | S | 110.00 | 10,000 | 1,100,000 | 5,637 | 15.6 K to 5.6 K (-63.95 %) |
| Apr 29 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Buy | M | 1.70 | 10,000 | 17,000 | 15,637 | 5.6 K to 15.6 K (+177.40 %) |
| Apr 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Sell | S | 108.00 | 10,000 | 1,080,000 | 5,637 | 15.6 K to 5.6 K (-63.95 %) |
| Apr 17 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Option Exercise | M | 40.74 | 10,000 | 407,400 | 35,000 | |
| Apr 17 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Sell | S | 105.00 | 10,000 | 1,050,000 | 15,637 | 25.6 K to 15.6 K (-39.01 %) |
| Apr 17 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Buy | M | 40.74 | 10,000 | 407,400 | 25,637 | 15.6 K to 25.6 K (+63.95 %) |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 57.56 | 24,600 | 1,415,976 | 15,000 | |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 40.32 | 15,263 | 615,404 | 21,668 | |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 40.32 | 2,769 | 111,646 | 36,931 | |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 96.08 | 39,863 | 3,830,037 | 468 | 40.3 K to 468 (-98.84 %) |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 57.56 | 24,600 | 1,415,976 | 40,331 | 15.7 K to 40.3 K (+156.38 %) |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 40.32 | 15,263 | 615,404 | 15,731 | 468 to 15.7 K (+3,261.32 %) |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 96.04 | 2,769 | 265,935 | 468 | 3.2 K to 468 (-85.54 %) |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 40.32 | 2,769 | 111,646 | 3,237 | 468 to 3.2 K (+591.67 %) |
| Apr 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Grant | A | 76.88 | 85 | 6,535 | 468 | 383 to 468 (+22.19 %) |
| Apr 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Option Exercise | M | 23.00 | 9,503 | 218,569 | 20,497 | |
| Apr 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Option Exercise | M | 0.95 | 10,000 | 9,500 | 8,964 | |
| Apr 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Sell | S | 93.76 | 29,503 | 2,766,201 | 15,637 | 45.1 K to 15.6 K (-65.36 %) |
| Apr 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Buy | M | 23.00 | 9,503 | 218,569 | 45,140 | 35.6 K to 45.1 K (+26.67 %) |
| Apr 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Buy | M | 0.95 | 10,000 | 9,500 | 35,637 | 25.6 K to 35.6 K (+39.01 %) |
| Apr 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Grant | A | 76.88 | 42 | 3,229 | 25,637 | 25.6 K to 25.6 K (+0.16 %) |